Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Clifford

Showing results (311-320 of 337) with videos related to

Pageof 34
Sort By:
Neuro-Oncology|July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapseStacey Richardson, Rebecca M Hill, Christopher Kui, et al.
Ecancermedicalscience|April 26, 2016
Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain TumoursAudrey Nailor, David A Walker, Thomas S Jacques, et al.
Science (New York, N.Y.)|July 18, 2024
Dynamics of high-speed electrical tree growth in electron-irradiated polymethyl methacrylateKathryn M Sturge, Noah Hoppis, Ariana M Bussio, et al.
Acta Neuropathologica|February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasMarcel Kool, Andrey Korshunov, Marc Remke, et al.
The Lancet. Oncology|June 14, 2012
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysisDaniel Picard, Suzanne Miller, Cynthia E Hawkins, et al.
Cancer Cell|December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable diseaseRebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
The Lancet. Oncology|December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastomaEnrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
Advances in Radiation Oncology|December 11, 2020
Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 TrialStefan Dietzsch, Felix Placzek, Klaus Pietschmann, et al.
Pageof 34

Showing results (311-320 of 337) with videos related to

Sort By:
Pageof 34
Neuro-Oncology|July 17, 2021
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapseStacey Richardson, Rebecca M Hill, Christopher Kui, et al.
Ecancermedicalscience|April 26, 2016
Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain TumoursAudrey Nailor, David A Walker, Thomas S Jacques, et al.
Science (New York, N.Y.)|July 18, 2024
Dynamics of high-speed electrical tree growth in electron-irradiated polymethyl methacrylateKathryn M Sturge, Noah Hoppis, Ariana M Bussio, et al.
Acta Neuropathologica|February 24, 2012
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasMarcel Kool, Andrey Korshunov, Marc Remke, et al.
The Lancet. Oncology|June 14, 2012
Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysisDaniel Picard, Suzanne Miller, Cynthia E Hawkins, et al.
Cancer Cell|December 24, 2014
Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable diseaseRebecca M Hill, Sanne Kuijper, Janet C Lindsey, et al.
The Lancet. Oncology|December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastomaEnrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Nature|December 15, 2010
Subtypes of medulloblastoma have distinct developmental originsPaul Gibson, Yiai Tong, Giles Robinson, et al.
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.
Advances in Radiation Oncology|December 11, 2020
Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 TrialStefan Dietzsch, Felix Placzek, Klaus Pietschmann, et al.
Pageof 34